Clinical Research Directory

Inclusion Criteria 1. Provision of signed and dated informed consent form 2. Stated willingness to comply with all study procedures and availability for the duration of the study 3. Being 18 to 54 years of age 4. Being a cis-gender male 5. Self-report one or more of the following behaviors and health conditions in the last 6 months which meet the Centers for Disease Control and Prevention (CDC) clinical guidelines for PrEP eligibility * Diagnosed with bacterial sexually transmitted infection (e.g., syphilis, gonorrhea, or chlamydia) * Sex with a partner who is living with HIV * Sex without a condom with two or more partners whose HIV status were unknown * Injection drug use and sharing injection equipment 6. Self-reported status as HIV negative 7. Willing to be tested for HIV Exclusion Criteria 1. Display diminished capacity to consent because of: * An inability to provide informed consent (e.g., cognitive impairment) * Severe psychiatric symptoms (e.g., mania, psychosis) that impair capacity to provide informed consent, as assessed by interviewers with Collaborative Institutional Training Initiative (CITI) Human Subjects Research and National Institutes of Health (NIH) Good Clinical Practice training 2. \<18 years old or \>54 years old 3. Self-reported living with HIV 4. Reactive HIV test (for "Amigx" seeds or "Yo Quiero" control participants) 5. Refusal of HIV test 6. Identifies as Non-Latinx 7. Individuals enrolled in other PrEP initiation interventions 8. Individuals with an active PrEP prescription in the last 6-months (oral or injectable)